Oxandrolonos 10 Pharmacom — Research Summary
Oxandrolone is a synthetic anabolic androgenic steroid originally developed in the 1960s as a modified derivative of dihydrotestosterone (DHT). This 17α-alkylated compound exhibits unique structural modifications that researchers at Stroid UK Shop investigate for its tissue-selective properties and reduced androgenic activity compared to testosterone. Pharmacom’s 10mg formulation provides standardised dosing for laboratory protocols examining anabolic steroid mechanisms in cellular and tissue models.
Research Applications
Laboratory studies examine oxandrolone’s mechanisms of action through androgen receptor binding and subsequent gene expression modulation. Researchers investigate its effects on protein synthesis pathways, nitrogen retention in tissue cultures, and comparative studies with other compounds from our oral steroids collection. The compound’s 17α-methylated structure makes it valuable for studying hepatic metabolism and oral bioavailability factors. Scientific investigations compare its tissue selectivity profiles with contemporary research compounds like those found in our SARMs and peptides categories for comprehensive androgenic pathway research.
Compound Specifications
| Active Compound | Oxandrolone |
|---|---|
| CAS Number | 53-39-4 |
| Molecular Formula | C₁₉H₃₀O₃ |
| Molecular Weight | 306.44 g/mol |
| Dosage Form | 10mg tablets |
| Manufacturer | Pharmacom Labs |
| Storage | Room temperature, dry conditions |
Research Use Statement
Oxandrolonos 10 Pharmacom is manufactured exclusively for in-vitro research applications and laboratory studies. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must comply with institutional guidelines and relevant legislation governing controlled substances in laboratory environments.

